- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04241016
Endoscopic Sinus Surgery in Recurrent Acute Rhinosinusitis
May 30, 2023 updated by: Olli-Pekka Alho, MD, Oulu University Hospital
A Randomised Controlled Study of Endoscopic Sinus Surgery for Recurrent Acute Rhinosinusitis
The aim of this study is to find out if endoscopic sinus surgery improves the quality of life in patients suffering from recurrent acute rhinosinusitis.
Our main outcome is the difference between the average change in disease-specific SNOT-22 quality of life questionnaire scores (from baseline to 5-6 months follow-up) between the intervention and the control groups.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This is a randomized controlled trial.
Patients suffering from recurrent acute sinusitis episodes will be randomly allocated to two groups: intervention group, where they will receive endoscopic sinus surgery in addition to medical treatment and control group, where they will receive mere medical treatment.
Both groups will be followed-up for 5 to 6 months.
At baseline and after 5 to 6 months, patients will answer the life quality questionnaires SNOT-22 and RAND 36-item Health Survey.
The numbers of sinusitis episodes, medical appointments for respiratory symptoms, use of medications, numbers of days lost from work or studies and numbers of days with various respiratory and adverse symptoms will be recorded with patient diaries.
The potential serious adverse events (e.g.
cerebrospinal fluid leak, orbital complications) related to surgery will be collected from the medical records.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Heidi M Kaski, MD
- Phone Number: +385442730022
- Email: heidi.kaski@student.oulu.fi
Study Locations
-
-
-
Oulu, Finland
- Recruiting
- Oulu University Hospital
-
Contact:
- Heidi M Kaski, MD
- Phone Number: +384442730022
- Email: heidi.kaski@student.oulu.fi
-
Tampere, Finland
- Recruiting
- Tampere university Hospital
-
Contact:
- Saara Sillanpää, MD
- Phone Number: +358 3 311 611
- Email: saara.sillanpaa@pirha.fi
-
Contact:
- Merja Rumpunen, Ms
- Phone Number: +358 3 311 611
- Email: merja.rumpunen@pirha.fi
-
Principal Investigator:
- Saara Sillanpää, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- At least 3 acute sinusitis episodes during previous 6 months or 4 acute sinusitis episodes during previous 12 months or at least 2 episodes per year for 3 consecutive years
- Episodes must last less than 4 weeks and be diagnosed and treated as acute rhinosinusitis by a physician
- Episode symptoms include nasal discharge, nasal congestion, hyposmia and facial pressure or pain and the episodes have to be severe enough for the patient to seek medical help and for daily life to be significantly disturbed
- Patients must have failed a three-month conservative therapy (medication for possible allergies, nasal corticosteroids and douching and courses of antibiotics as necessary)
Exclusion Criteria:
- Age under 18 years,
- Immunodeficiency or immunosuppression
- Pregnancy,
- Previous illness making same-day surgery unfeasible
- Ongoing antibiotic treatment for other reasons,
- Primary complaint of nasal septal deviation and
- Chronic rhinosinusitis with or without nasal polyposis
- Symptoms for over 12 weeks and/or Lund-Mackay score over 8 in paranasal sinus CBCT scanning
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Endoscopic sinus surgery (ESS)
Endoscopic sinus surgery.
Postoperative treatment consists of daily nasal douching, daily nasal steroid sprays, pain medication when necessary and at least one postoperative control visit including endoscopy two weeks after the operation.
Additionally medical treatment including nasal corticosteroids, nasal douching and other allergy medication as necessary.
|
Uncinectomy, middle meatal antrostomy by enlarging the natural maxillary ostium and partial ethmoidectomy or septoplasty according to clinical evaluation of the operator.
|
No Intervention: Control
Conservative treatment including nasal corticosteroids, nasal douching and other allergy medication as necessary.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sinonasal Outcome Test-22 score
Time Frame: 5-6 months
|
Difference between the mean disease-specific Sinonasal Outcome Test 22 (SNOT-22) change scores (from baseline to 5-6 months) of ESS and control group.
SNOT-22 summary scores vary between 0 and 110 with higher values indicating poorer quality of life.
|
5-6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
36-Item Short Form Survey (SF-36, RAND) score
Time Frame: 5-6 months
|
Difference between the mean generic RAND-36 domains change scores (from baseline to 5-6 months) of ESS and control group.
RAND-36 instrument produces eight individual values between 0 and 100 (one for each domain), with higher scores indicating better quality of life.
|
5-6 months
|
Difference in proportions of patients benefiting
Time Frame: 5-6 months
|
Difference in proportions of patients benefiting clinically significantly from the treatment in ESS and control group (Minimum important change in SNOT-22 score)
|
5-6 months
|
Difference in numbers of sinusitis episodes
Time Frame: 5-6 months
|
Difference in the numbers of sinusitis episodes between the ESS and control groups.
|
5-6 months
|
Difference in numbers of medical visits
Time Frame: 5-6 months
|
Difference in the numbers of medical visits between the ESS and control groups.
|
5-6 months
|
Difference in numbers of antimicrobial treatments
Time Frame: 5-6 months
|
Difference in the numbers of antimicrobial treatments between the ESS and control groups.
|
5-6 months
|
Difference in numbers of days lost from work or studies
Time Frame: 5-6 months
|
Difference in the numbers of days lost from work or studies between the ESS and control groups.
|
5-6 months
|
Difference in numbers of days with nasal obstruction
Time Frame: 5-6 months
|
Difference in the numbers of days with nasal obstruction between the ESS and control groups.
|
5-6 months
|
Difference in numbers of days with nasal discharge
Time Frame: 5-6 months
|
Difference in the numbers of days with nasal discharge between the ESS and control groups.
|
5-6 months
|
Difference in numbers of days with facial pain or pressure
Time Frame: 5-6 months
|
Difference in the numbers of days with facial pain or pressure between the ESS and control groups.
|
5-6 months
|
Difference in numbers of days with nasal pain
Time Frame: 5-6 months
|
Difference in the numbers of days with nasal pain between the ESS and control groups.
|
5-6 months
|
Difference in numbers of days with nasal hemorrhage
Time Frame: 5-6 months
|
Difference in the numbers of days with nasal hemorrhage between the ESS and control groups.
|
5-6 months
|
Difference of numbers of days with fever
Time Frame: 5-6 months
|
Difference in the numbers of days with fever (>37.5 Celsius) between the ESS and control groups.
|
5-6 months
|
Adverse effects - postoperative synechia formation
Time Frame: 5-6 months
|
Frequency of postoperative synechia formations in the ESS group
|
5-6 months
|
Adverse effects - postoperative infection
Time Frame: 5-6 months
|
Frequency of postoperative infections in the ESS group
|
5-6 months
|
Adverse effects - postoperative orbital complication
Time Frame: 5-6 months
|
Frequency of postoperative orbital complications in the ESS group
|
5-6 months
|
Adverse effects - postoperative intracranial complication
Time Frame: 5-6 months
|
Frequency of postoperative intracranial complications in the ESS group
|
5-6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Olli-Pekka Alho, MD, PhD, Oulu University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2020
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
May 30, 2025
Study Registration Dates
First Submitted
January 17, 2020
First Submitted That Met QC Criteria
January 22, 2020
First Posted (Actual)
January 27, 2020
Study Record Updates
Last Update Posted (Actual)
May 31, 2023
Last Update Submitted That Met QC Criteria
May 30, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 01234
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sinusitis
-
Loma Linda UniversityWithdrawnChronic Sinus Disease | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Maxillary Bilateral | Chronic Sinusitis - Frontoethmoidal
-
LifeBridge HealthUnknownChronic Sinusitis | Nasal Polyps | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Frontoethmoidal | Chronic Sinusitis - Ethmoidal, Posterior | Chronic Sinusitis - Ethmoidal Anterior | Nasal Polyp - PosteriorUnited States
-
Tampere University HospitalRecruitingMaxillary Sinusitis | Eustachian Tube Dysfunction | Sinusitis, Chronic | Sinusitis RecurrentFinland
-
Collin County Ear Nose & ThroatIntersect ENTCompletedChronic Sinusitis, EthmoidalUnited States
-
STS MedicalNot yet recruitingChronic Sinusitis, Ethmoidal
-
St. Louis UniversityTerminatedStent | Sinusitis, FrontalUnited States
-
Cairo UniversityNot yet recruitingChronic Maxillary Sinusitis
-
Centre Hospitalier Intercommunal CreteilActive, not recruitingChronic Maxillary SinusitisFrance
-
DeyCompletedACUTE SINUSITISUnited States
-
University of California, Los AngelesWithdrawnChronic Sinusitis | Frontal SinusitisUnited States
Clinical Trials on Endoscopic sinus surgery (ESS)
-
Zheng LiuRecruitingProgression | Chronic Sinusitis | Surgery | Radiology | PathologyChina
-
State University of New York - Upstate Medical...TerminatedChronic Sinusitis | Adenoid Disease - ChronicUnited States
-
Helsinki University Central HospitalActive, not recruitingAsthma | Nasal Polyps | Aspirin Sensitivity | Sinusitis, ChronicFinland, Netherlands
-
Oregon Health and Science UniversityMedical University of South CarolinaActive, not recruitingChronic Rhinosinusitis | Olfactory Dysfunction
-
Beijing Tongren HospitalCompletedChronic Rhinosinusitis (Diagnosis) | Surgery
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
Zheng LiuRecruitingChronic Sinusitis | Nasal Polyps | Endoscopic Sinus SurgeryChina
-
Instituto Nacional de Enfermedades RespiratoriasUnknownSleep | Aspirin-exacerbated Respiratory DiseaseMexico
-
University of California, San FranciscoCompletedAsthma | Chronic RhinosinusitisUnited States
-
Entellus Medical, Inc.CompletedChronic SinusitisUnited States